FIRST LINE TREATMENT OF ADVANCED OVARIAN CANCER WITH PACLITAXEL/EPIRUBICIN/CARBOPLATIN (TEC) VS PACLITAXEL/CARBOPLATIN (TC). INTERIM RESULTS OF AN NSGO-EORT-GCG-NCIC-CTG GYNECOLOGICAL CANCER INTERGROUP PHASE III TRIAL. Issue 1 (1st March 2003) - Stuart, G.